Back to top

Beta Bionics price target lowered to $30.40 from $32 at Ladenburg

Ladenburg analyst Jeffrey Cohen lowered the firm’s price target on Beta Bionics (BBNX) to $30.40 from $32 and keeps a Buy rating on the shares. Pub...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: